XML 46 R12.htm IDEA: XBRL DOCUMENT
v2.4.0.8

STOCK BASED COMPENSATION | 9 Months Ended
--- | ---
Sep. 30, 2014
Stock-Based Compensation Arrangements |
STOCK BASED COMPENSATION |
| 6. | STOCK BASED COMPENSATION
ASC 718 requires compensation expense associated with share-based awards to be recognized over the requisite service period, which for the Company is the period between the grant date and the date the award vests or becomes exercisable. Most of the awards granted by the Company (and still outstanding), vest ratably over one to four years. The Company recognizes all share-based awards under the straight-line attribution method. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company evaluates its forfeiture assumptions quarterly and the expected forfeiture rate is adjusted when necessary. Ultimately, the actual expense recognized over the vesting period is based on only those shares that vest. Stock based compensation has been reported within expense line items on the consolidated statement of operations for the three and nine months ended September 30, 2013 and 2014 as shown in the following table (in $000s):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2013 |  |  | 2014 |  |  | 2013 |  |  | 2014 |
General and administrative |  | $ | 82 |  |  | $ | 160 |  |  | $ | 199 |  |  | $ | 415 |
Research and development |  |  | 15 |  |  |  | 59 |  |  |  | 44 |  |  |  | 174 |
Stock-based compensation costs before income taxes |  | $ | 97 |  |  | $ | 219 |  |  | $ | 243 |  |  | $ | 589 |
2006 Plan On March 16, 2006, the 2006 Plan was adopted, under which Cyclacel may make equity incentive grants to its officers, employees, directors and consultants. The Company has reserved 1,428,571 shares of the Company’s common stock under the 2006 Plan. Stock option awards granted under the 2006 Plan have a maximum life of 10 years and generally vest over a one to four-year period from the date of grant. There were 32,697 and 63,000 options granted during the nine months ended September 30, 2013 and 2014, respectively. There were no stock options exercised during the three and nine months ended September 30, 2013 and 2014. The Company does not expect to be able to benefit for the deduction for stock option exercises that may occur during the year ended December 31, 2014 because the company has tax loss carryforwards from prior periods that would be expected to offset any potential taxable income for the year ended December 31, 2014. Outstanding Options A summary of the share option activity and related information is as follows:
|  | Number of Options Outstanding |  |  | Weighted Average Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value ($000) |
Options outstanding at December 31, 2013 |  |  | 949,685 |  |  | $ | 15.02 |  |  |  | 7.38 |  |  | $ | 152 |
Granted |  |  | 63,000 |  |  | $ | 3.11 |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  | $ | — |  |  |  |  |  |  |  |  |
Cancelled/forfeited |  |  | (2,387 | ) |  | $ | 31.08 |  |  |  |  |  |  |  |  |
Options outstanding at September 30, 2014 |  |  | 1,010,298 |  |  | $ | 14.24 |  |  |  | 6.83 |  |  | $ | 7 |
Unvested at September 30, 2014 |  |  | 449,915 |  |  | $ | 4.15 |  |  |  | 9.16 |  |  | $ | 1 |
Vested and exercisable at September 30, 2014 |  |  | 560,383 |  |  | $ | 22.33 |  |  |  | 4.96 |  |  | $ | 6 |
The fair value of the stock options granted is calculated using the Black-Scholes option-pricing model as prescribed by ASC 718. The expected term assumption is estimated using past history of early exercise behavior and expectations about future behaviors. Estimates of pre-vesting option forfeitures are based on the Company’s experience. Currently the Company uses a forfeiture rate of 0 - 30% depending on when and to whom the options are granted. The Company adjusts its estimate of forfeitures over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures are recognized through a cumulative adjustment in the period of change and may impact the amount of compensation expense to be recognized in future periods. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. The weighted average risk-free interest rate represents interest rate for treasury constant maturities published by the Federal Reserve Board. If the term of available treasury constant maturity instruments is not equal to the expected term of an employee option, Cyclacel uses the weighted average of the two Federal Reserve securities closest to the expected term of the employee option. Restricted Stock Units Summarized information for restricted stock unit activity for the nine months ended September 30, 2014 is as follows:
|  | Restricted Stock Units (1) |  |  | Weighted Average Grant Date Value Per Share |
Non-vested at December 31, 2013 |  |  | 119,248 |  |  | $ | 5.62 |
Granted |  |  | — |  |  | $ | — |
Forfeited |  |  | (233 | ) |  | $ | 5.39 |
Non-vested at September 30, 2014 |  |  | 119,015 |  |  | $ | 5.62 |
| (1) | Includes 85,097 restricted stock units issued that will vest upon the fulfillment of certain clinical and financial conditions.
The Company issued 85,097 restricted stock units to employees during the three months ended March 31, 2013 that will vest upon the fulfillment of certain clinical and financial conditions and will terminate if they have not vested by December 31, 2014. The Company determined that the satisfaction of the vesting criteria was not probable as of September 30, 2014 and, as a result, did not record any expense related to these awards for the three and nine months ended September 30, 2014. The Company did not issue any restricted stock units during the nine months ended September 30, 2014.

X
- Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration